Newsroom

Grantee News · September 21, 2021
A new $13.3 million contract from the NIH's Rapid Acceleration of Diagnostics (RADx) initiative will enable the David Geffen School of Medicine at UCLA to expand its capacity to process COVID-19 tests.
Grantee News · September 14, 2021
Engineers developed a way to grow tiny replicas of the pancreas, using either healthy or cancerous pancreatic cells. Their models could help researchers develop and test potential drugs for pancreatic cancer.
Grantee News · September 10, 2021
As mice watched movies, scientists watched their brains to see how vision could be represented reliably. The answer is that consistency in representation is governed by a circuit of inhibitory neurons. Source: The Picower Institute for Learning and Memory at MIT.
Grantee News · September 8, 2021
Equipped with a color 3D camera, an inertial measurement sensor, and its own on-board computer, a newly improved robotic cane could offer blind and visually impaired users a new way to navigate indoors. Development of the device was co-funded by NIBIB the NEI. Source: National Eye Institute.
Grantee News · August 31, 2021
Researchers have developed a capsule that can carry large protein drugs, such as monoclonal antibodies, and inject them directly into the lining of the stomach.
Grantee News · August 30, 2021
The human body can be genetically inclined to attack its own cells, destroying the beta cells in the pancreas that make insulin, which helps convert sugar into energy. Called Type 1 diabetes, this disorder can occur at any age and can be fatal if not carefully managed with insulin shots or an insulin pump to balance the body's sugar levels.
Grantee News · August 19, 2021
A Rice University bioengineer and her Brown School of Engineering team were awarded an NIH grant to create gene activity sensors and activators that hold unmatched potential for the treatment of infectious diseases, diabetes, genetic disorders, and cancer. Source: AZO Life Sciences
Grantee News · July 29, 2021
Estimates developed by PHICOR, a public health research group, suggest that more than 40 percent of U.S. residents may not be sufficiently protected against the Delta variant. Source: New York Times. New York Times.
Grantee News · July 26, 2021
Researchers are pushing organ-on-a-chip devices to new levels that could change the way clinicians approach cancer treatment, particularly ovarian cancer.